Author

Lingzhi Zhu

Fudan University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:experimental assay· 1 Assay:metabolomics· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Fei LiiD· 1 shared Fuming LiiD· 1 shared Jianwei You· 1 shared Junfeng BiiD· 1 shared Li YangiD· 1 shared Liucheng LiiD· 1 shared Pingyu Liu· 1 shared Wen Mi· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Fei LiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BET inhibition induces GDH1-dependent glutamine metabolic remodeling and vulnerability in liver cancer

Wen Mi, Jianwei You, Liucheng Li, Lingzhi Zhu, Xinyi Xia, Li Yang, Fei Li, Yi Xu, Junfeng Bi, Pingyu Liu, Fuming Li

This study shows BET inhibition in liver cancer reduces proliferation by inducing GDH1-dependent glutamine metabolic changes, suggesting a therapeutic strategy combining BET and OXPHOS inhibitors.

Life Metabolism · Apr 24, 2024Peer-reviewedCancer Biology